Loading...
NOVT
XNAS
Market cap3.86bUSD
Nov 20, Last price  
101.99USD
1D
-11.22%
1Q
-29.78%
Jan 2017
385.67%
Name

Novanta Inc

Chart & performance

D1W1MN
XNAS:NOVT chart
P/E
71.66
P/S
3.93
EPS
1.42
Vol. 1Y
52.65%
Shs. 5Y
0.58%
Rev. 5Y
10.67%
Div Yld LY
—
Div Yld TTM
—
Revenues
981m
+3.30%
313,609,000291,081,000288,468,000254,388,000383,516,000366,280,000271,498,000341,612,000364,706,000373,598,000384,758,000521,290,000614,337,000626,099,000590,623,000706,793,000860,903,000881,662,000949,245,000980,600,000
Net income
54m
-16.01%
21,743,00015,155,000-203,847,000-71,330,000-687,00028,973,00019,538,0007,309,000-24,252,00035,615,00022,003,00060,051,00049,109,00040,773,00044,521,00050,331,00074,051,00072,878,00064,087,00053,829,000
CFO
64m
-59.59%
35,256,00037,488,00038,902,000-25,786,000-4,738,00045,173,00028,430,00049,200,00042,289,00033,416,00047,788,00063,378,00089,647,00063,248,000140,239,00094,625,00090,779,000120,075,000158,512,00064,056,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Operating globally, Novanta Inc. and its affiliated companies specialize in the development, production, and distribution of advanced photonics, vision, and precision motion components and sub-assemblies. These highly engineered solutions are supplied to Original Equipment Manufacturers (OEMs) across the medical and industrial sectors. Within its Photonics division, Novanta provides a suite of laser-driven technologies. These encompass systems for laser scanning, beam manipulation, and various laser types such as CO2, solid-state, ultrafast, and optical light engines. Their applications span critical areas like industrial manufacturing, precision measurement (metrology), advanced imaging in healthcare and biological research, DNA sequencing, and specialized medical laser treatments. The Vision segment delivers an array of medical-grade innovations. This portfolio comprises instruments like medical insufflators, pumps, and their associated consumables, alongside comprehensive visualization tools. It also features wireless communication systems, video recording devices, and integration platforms designed for operating theaters. Further offerings include optical data acquisition, machine vision systems, radio frequency identification (RFID) solutions, thermal recording devices, spectrometry equipment, and integrated touchscreen displays. Furthermore, the Precision Motion division specializes in supplying components such as optical and inductive encoders, high-precision motors, servo drives, and complete motion control systems. This segment also delivers integrated stepper motors, sophisticated robotic end-effectors, air bearings, and air bearing spindles. Novanta distributes its extensive product lines through various channels, including its dedicated direct sales team, value-added resellers, distribution partners, and system integrators. These offerings are available under well-known brand names such as Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Founded in 1968, the company operated as GSI Group, Inc. until its rebranding to Novanta Inc. in May 2016. Its corporate headquarters are located in Bedford, Massachusetts.

Key people

Chairman of the Board, Chief Executive Officer · since 2021
Robert Buckley
Chief Financial Officer · since 2021
John Lesica
Co-Chief Operating Officer - Medical Solutions · since 2025
Chuck Ravetto
Co-Chief Operating Officer - Automation Enabling Technologies · since 2025
Mary Ladone
Director · since 2024
Lead Independent Director · since 2021
Independent Director · since 2024
Independent Director · since 2020
Thomas Secor
Independent Director · since 2012
Independent Director · since 2022
Independent Director · since 2021
IPO date
Mar 24, 1999
Employees
3,000
Domiciled in
US
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT